Brief: Amniotics Q3 EBITDA Loss at SEK 5.6 Million
27/11/2023 07:02
Nov 27 (Reuters) - Amniotics Q3 net income SEK -6.7 million. * Q3 EBITDA SEK -5.6 million * Q3 EPS SEK -0.03
Recent news on Amniotics AB (publ)
See all newsBrief: Swedish Companies Registration Office Authorises Magle Group, Amniotics Merger Plan
Brief: Amniotics H1 Net Revenue SEK 2.5 Million
Brief: Amniotics Gets Conditional Approval To Delist From Nasdaq First North Growth Market
Brief: Amniotics To Delist From Nasdaq First North Growth Market Upon Magle Group Merger Completion
Brief: Magle Chemoswed, Amniotics Adopt Merger Plan